1. Home
  2. GIX vs MASS Comparison

GIX vs MASS Comparison

Compare GIX & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GIX

GigCapital9 Corp. Class A Ordinary Share

N/A

Current Price

$9.95

Market Cap

360.7M

Sector

Finance

ML Signal

N/A

Logo 908 Devices Inc.

MASS

908 Devices Inc.

N/A

Current Price

$8.76

Market Cap

326.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GIX
MASS
Founded
2025
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
360.7M
326.0M
IPO Year
2026
2020

Fundamental Metrics

Financial Performance
Metric
GIX
MASS
Price
$9.95
$8.76
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
7.3K
234.4K
Earning Date
N/A
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
125.47
EPS
N/A
N/A
Revenue
N/A
$56,197,000.00
Revenue This Year
N/A
$19.44
Revenue Next Year
N/A
$18.63
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.80
$5.03
52 Week High
$9.95
$9.34

Technical Indicators

Market Signals
Indicator
GIX
MASS
Relative Strength Index (RSI) 75.36 61.25
Support Level N/A $7.57
Resistance Level N/A $9.20
Average True Range (ATR) 0.00 0.49
MACD 0.00 -0.00
Stochastic Oscillator 91.67 77.70

Price Performance

Historical Comparison
GIX
MASS

About GIX GigCapital9 Corp. Class A Ordinary Share

GigCapital9 Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses.

About MASS 908 Devices Inc.

908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.

Share on Social Networks: